| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sandeep Grover, Anish Shouan, Subho Chakrabarti, Swapnajeet Sahoo, Aseem Mehr. Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS). Nordic journal of psychiatry. vol 75. issue 6. 2021-08-03. PMID:33630681. |
comparative study of effectiveness of augmentation with ect in clozapine resistant schizophrenia (crs) and non-clozapine resistant schizophrenia (non-crs). |
2021-08-03 |
2023-08-13 |
Not clear |
| Sandeep Grover, Anish Shouan, Subho Chakrabarti, Swapnajeet Sahoo, Aseem Mehr. Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS). Nordic journal of psychiatry. vol 75. issue 6. 2021-08-03. PMID:33630681. |
there is limited evidence for different treatment strategies in patients with clozapine resistant schizophrenia (crs). |
2021-08-03 |
2023-08-13 |
Not clear |
| Anna Maria Szota, Izabela Radajewska, Aleksander Stanisław Araszkiewic. Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges. Journal of psychoactive drugs. 2021-08-03. PMID:34340640. |
atypical neuroleptic malignant syndrome was found to develop mainly in male patients suffering from schizophrenia (14 cases) and bipolar disorder (2), and was induced by clozapine (6 cases), olanzapine (5 cases), aripiprazole and quetiapine (4 cases). |
2021-08-03 |
2023-08-13 |
Not clear |
| Francesca Martini, Marco Spangaro, Mariachiara Buonocore, Margherita Bechi, Federica Cocchi, Carmelo Guglielmino, Laura Bianchi, Jacopo Sapienza, Giulia Agostoni, Antonella Mastromatteo, Marta Bosia, Roberto Cavallar. Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex. Psychiatry research. vol 297. 2021-07-30. PMID:33440269. |
clozapine tolerability in treatment resistant schizophrenia: exploring the role of sex. |
2021-07-30 |
2023-08-13 |
Not clear |
| Francesca Martini, Marco Spangaro, Mariachiara Buonocore, Margherita Bechi, Federica Cocchi, Carmelo Guglielmino, Laura Bianchi, Jacopo Sapienza, Giulia Agostoni, Antonella Mastromatteo, Marta Bosia, Roberto Cavallar. Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex. Psychiatry research. vol 297. 2021-07-30. PMID:33440269. |
clozapine is the only evidence-based drug indicated for treatment resistant schizophrenia but it is largely underprescribed, partially due to its life-threatening adverse effects (aes). |
2021-07-30 |
2023-08-13 |
Not clear |
| Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabart. Starting clozapine in patients with schizophrenia during the ongoing pandemic. Schizophrenia research. 2021-07-29. PMID:34303594. |
starting clozapine in patients with schizophrenia during the ongoing pandemic. |
2021-07-29 |
2023-08-13 |
Not clear |
| Jennifer Erley, Sarah Goldsborough, Amy VandenBerg, Alexandra Aud. Loxapine in patient with clozapine-resistant psychosis. The mental health clinician. vol 11. issue 4. 2021-07-29. PMID:34316424. |
this case describes a 57-year-old male with a history of severe paranoid schizophrenia despite treatment with clozapine and other psychotropic agents, who experienced clinical improvement after a cross titration from clozapine to loxapine. |
2021-07-29 |
2023-08-13 |
Not clear |
| Jennifer Erley, Sarah Goldsborough, Amy VandenBerg, Alexandra Aud. Loxapine in patient with clozapine-resistant psychosis. The mental health clinician. vol 11. issue 4. 2021-07-29. PMID:34316424. |
loxapine may be a reasonable alternative in patients with treatment-refractory schizophrenia who do not tolerate or respond to clozapine. |
2021-07-29 |
2023-08-13 |
Not clear |
| Sujatha Sanjeevi, Angela Cocoma. Mental Health Nurses' Knowledge of Clozapine. Issues in mental health nursing. vol 42. issue 3. 2021-07-28. PMID:32762588. |
clozapine, sold under the brand name clozaril, is an antipsychotic medication prescribed since the 1970s as an effective treatment for individuals with treatment resistive schizophrenia. |
2021-07-28 |
2023-08-13 |
Not clear |
| Dan-Sheng Le, Heng Su, Zheng-Luan Liao, En-Yan Y. Low-dose clozapine-related seizure: A case report and literature review. World journal of clinical cases. vol 9. issue 20. 2021-07-27. PMID:34307616. |
treatment-resistant schizophrenia is a severe form of schizophrenia characterized by poor response to at least two antipsychotic drugs and is typically treated with clozapine. |
2021-07-27 |
2023-08-13 |
Not clear |
| Arthur S Nguyen, Rebecca Grossman-Kahn, Lora Wichse. Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use. Journal of clinical psychopharmacology. vol 40. issue 6. 2021-07-26. PMID:33065717. |
anticipatory clozapine dosing after discharge from inpatient treatment for the patient with comorbid schizophrenia and tobacco use. |
2021-07-26 |
2023-08-13 |
Not clear |
| Petros Drosos, Kolbjørn Brønnick, Inge Joa, Jan Olav Johannessen, Erik Johnsen, Rune Andreas Kroken, Helen Joy Stain, Wenche Ten Velden Hegelstad, Tor Ketil Larse. One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study. Journal of clinical psychopharmacology. vol 40. issue 6. 2021-07-26. PMID:33136922. |
international guidelines for the pharmacological treatment of schizophrenia recommend a 3-step algorithm with clozapine being the third-line antipsychotic agent. |
2021-07-26 |
2023-08-13 |
Not clear |
| Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan, Chuen-Fu Li. Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. International journal of molecular sciences. vol 22. issue 13. 2021-07-23. PMID:34206460. |
clozapine is widely employed in the treatment of schizophrenia. |
2021-07-23 |
2023-08-13 |
mouse |
| Mariko Tsukiji, Tsuyoshi Sasaki, Yusuke Nakata, Kiyomitsu Ota, Tsutomu Aoki, Koichiro Hara, Takashi Mamada, Jun Nakane, Masanobu Kogure, Ryota Seki, Keita Idemoto, Tasuku Hashimoto, Hiraki Koishikawa, Toshihiro Moriyama, Takaaki Suzuki, Nobuhisa Kanahara, Itsuko Ishii, Masaomi Iyo, Tomihisa Niits. Risk factors for early-phase clozapine discontinuation: A nested case-control study. Asian journal of psychiatry. vol 62. 2021-07-21. PMID:34216977. |
safe and efficient methods for introducing clozapine to patients with treatment-resistant schizophrenia (trs) are needed. |
2021-07-21 |
2023-08-13 |
Not clear |
| Elias Ghossoub, Amanie Salem, Susan Minchin, Davinder Hayreh, William J Newma. A Retrospective Review of the Use of Clozapine in Restoration of Competency to Stand Trial. The journal of the American Academy of Psychiatry and the Law. vol 49. issue 1. 2021-07-19. PMID:33246989. |
clozapine has been shown to be superior to other antipsychotic medications in treatment-resistant schizophrenia. |
2021-07-19 |
2023-08-13 |
Not clear |
| Jianhua Chen, Ping Yang, Qian Zhang, Ruirui Chen, Peng Wang, Benxiu Liu, Wensheng Sun, Xuemin Jian, Siying Xiang, Juan Zhou, Ningning Li, Ke Wang, Chengwen Gao, Yanqin Wen, Chuanhong Wu, Jinmai Zhang, Yalin Zhao, Qiangzhen Yang, Meihang Li, Robert Stewart, Yuanchao Sun, Dun Pan, Yujuan Niu, Zhuo Wang, Yifeng Xu, Xingwang Li, Lin He, Zhiqiang Li, Yongyong Sh. Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study. Translational psychiatry. vol 11. issue 1. 2021-07-14. PMID:34083506. |
clozapine is considered to be the most effective antipsychotic medication for schizophrenia. |
2021-07-14 |
2023-08-13 |
Not clear |
| Henrik Maagensen, Julie R Larsen, Niklas R Jørgensen, Anders Fink-Jensen, Tina Vilsbøl. Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes - randomized controlled trial. Psychiatry research. vol 296. 2021-07-13. PMID:33373806. |
as liraglutide has been proposed to affect bone metabolism, we evaluated the effect of liraglutide on bone turnover markers (btm) in patients with prediabetes and schizophrenia treated with olanzapine or clozapine. |
2021-07-13 |
2023-08-13 |
Not clear |
| Gamze Gürcan, Şevin Hun Şenol, A Elif Anıl Yağcıoğlu, Aygün Ertuğru. Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms. Psychiatry research. vol 296. 2021-07-13. PMID:33465593. |
the aim of this study was to investigate the clinical risk factors, phenomenology and the impact of clozapine induced obsessive-compulsive symptoms (ocs) in patients with schizophrenia. |
2021-07-13 |
2023-08-13 |
Not clear |
| R Jones, J H MacCabe, M J Price, X Liu, R Upthegrov. Effect of age on the relative efficacy of clozapine in schizophrenia. Acta psychiatrica Scandinavica. vol 142. issue 2. 2021-07-12. PMID:31977065. |
effect of age on the relative efficacy of clozapine in schizophrenia. |
2021-07-12 |
2023-08-13 |
Not clear |
| H Verdoux, C Quile. Educational needs and psychoeducation interventions in clozapine users: a narrative review. Acta psychiatrica Scandinavica. vol 142. issue 2. 2021-07-12. PMID:32266962. |
increasing users' knowledge about the expected benefits and risks of clozapine may contribute to the initiation and maintenance of clozapine in persons with treatment-resistant schizophrenia (trs). |
2021-07-12 |
2023-08-13 |
Not clear |